When Burkitt's lymphoma (BL) was first described it was believed to be confined to certain parts of equatorial Africa and New Guinea coincident with holoendemic malarial infection. However, sporadic cases of the disease indistinguishable from BL on histological grounds began to be reported from countries outside these endemic areas (Burkitt, 1967) . In addition to the histological similarities, both endemic and sporadic cases of BL display the same characteristic chromosomal translocation involving the long arm of chromosome 8 and a region of chromosome 14 or 2 or 22 near the relevant immunoglobulin gene locus (Lenoir et al., 1982) . However, there are significant differences between the two geographically separate forms of the disease. Firstly, they show different anatomical distributions. Endemic BL tends to involve the jaw and gonads whereas sporadic BL tends to involve the gastrointestinal tract, bone marrow or peripheral lymph nodes (Wright & Isaacson, 1983) . Secondly, the Epstein-Barr (EB) virus is present in the malignant cells in at least 96% of endemic BL cases but in only a minority (15-20%) of sporadic BL cases (Ziegler et al., 1976) .
Debate continues as to whether BL should be considered as a single clinical entity, or should be classified into separate endemic and sporadic forms, or alternatively, into separate EB virus genome-positve and -negative forms (zur Hausen, 1975; de The et al., 1978) . In this context Rowe et al. (1985) have compared a number of EB virus-positive BL lines from both endemic and sporadic tumours for cell surface phenotype as defined by the cells' reactivity with a panel of monoclonal antibodies against B cell associated antigens. Cell lines derived from the two forms of virus-associated BL showed different ranges of phenotype and different growth patterns even within the first few in vitro passages. This suggested that the two forms of the tumour may be derived from distinct subsets of B cells in vivo, but the question could not be unequivocally resolved in the absence of data on fresh biopsy cells.
It was clearly important to extend this type of approach, analysing both tumour biopsy cells and the derived cell line, to cases of sporadic BL which were negative for the EB virus genome. The recent diagnosis of an EB virus-negative Burkitt-like lymphoma presenting in an English child provided the opportunity to characterise both the biopsy cells and the subsequent cell line from this tumour with the same panel of monoclonal antibody markers as used in the earlier work.
Materials and methods

Clinical history
The patient, DH, was an English male aged 8 years. Two weeks before admission he developed spasms of backache and ten days before admission complained of intermittent abdominal and limb pains. There was no significant past history or family history.
On examination he was found to have a palpable suprapubic mass 11 cm x 9 cm, arising from the pelvis. There was no palpable lymphadenopathy or hepatosplenomegaly. Ultrasound confirmed that the mass was solid in nature and showed dilated collecting systems of both kidneys, indicating mild ureteric obstruction. An exploratory laparotomy and biopsy were undertaken and imprints of the tumour showed lymphoblasts of characteristic L3 morphology (Bennett et al., 1976) . Bone marrow aspirate, trephine biopsy and lumbar puncture for cerebral spinal fluid cytology, showed no evidence of disease elsewhere.
The patient was treated according to a modification of the UKCCSG NHL protocol (Mott et al., 1984) . There was dramatic regression of the disease within hours of initiation of the treatment. Since that time, a period of 27 months, he has remained well with no evidence of recurrent disease.
The following specimens were obtained from the patient before therapy was commenced: heparinized peripheral blood (10Uml-1) and ascites fluid collected in sterile tissue culture medium. The patient's plasma was found to be negative for IgG antibodies to EB VCA when tested by direct immunofluorescence (Henle & Henle, 1966) .
Cell culture All cultures were carried out in RPMI 1640 medium supplemented with 2 mM glutamine, pencillin (100 IU ml -1), streptomycin (100 pg ml -1) and 10% v/v foetal calf serum (FCS) (Sera Lab., Crawley Down, Sussex, UK).
(a) Establishment of lymphoma-derived cell line (DH-BL) Viable mononuclear cells were isolated from the ascites sample by centrifugation over Ficoll-Hypaque by standard techniques. Aliquots of tumour cells were immediately cryopreserved in liquid nitrogen. Fresh tumour cells were cultured on human embryo fibroblasts in 2ml Linbro plates at 106 tumour cells per well as described fully elsewhere . The cultures were fed by replacing half the medium twice weekly. When growth commenced, the cells were initially subcultured onto fresh feeder cells and then into plastic tissue culture flasks.
(b) Establishment of lymphoblastoid cell line (DH-LCL) Mononuclear cells were separated from the whole blood by the method of Boyum (1968) . Normal B cells within this population were infected with the B95-8 strain of EB virus exactly as in earlier work (Moss et al., 1978; Finerty et al., 1982) to give an EB virus-transformed B-lymphoblastoid cell line (LCL) of non-malignant origin. The LCL was maintained by replacing half the medium twice weekly.
Immunofluorescence tests 1. EB nuclear antigen (EBNA) Cell smears were fixed in methanol:acetone (1:2) for 5min at -20°C and stored at -20°C until required. The slides were stained for EBNA as described elsewhere (Crawford et al., 1978) .
2. Surface and cytoplasmic immunoglobulin Cells were analysed for surface and cytoplasmic immunoglobulin by standard direct immunofluorescence as previously described (Finerty et al., 1982) . Biopsy cells were also analysed for surface immunoglobulin by the method of Gregory et al. (1985) .
3. Surface phenotyping using monoclonal antibodies The expression of various antigens at the cell surface was examined by indirect immunofluorescence using a panel of monoclonal antibodies referred to in Table I . Monoclonal antibodies MHM6, AC2, Ki-1, were used at dilutions of 1:100 to 1:500 of ascitic fluid preparations. The antibodies Bl, J5 and OKT1 1 were obtained commercially and used as recommended by the suppliers. The FITCconjugated second-step polyclonal antisera employed were a 1:100 dilution of goat anti-mouse IgG (Sigma, London) or, for the 38.13 rat monoclonal antibody, a 1:20 dilution of goat antirat IgM (Nordic Immunological Laboratories Ltd., Maidenhead), using as the diluent phosphate buffered saline (PBS) containing 10% EB virus antibody negative normal human serum and 10% normal goat serum.
The surface phenotyping was carried out as previously described: (a) on biopsy cells as described by Gregory et al., (1985) and (b) on early in vitro passages of the cell lines under test as described by Rowe et al. (1985) .
Chromosomal analysis Chromosome spreads were prepared and G-banded following the method of Autio and Schroder (1982) . Briefly, desiccated chromosome slides were incubated at 60°C in 2 x SSC overnight, treated with 0.1% trypsin (Gibco Ltd., Paisley, Scotland) in PBS for 20 sec and stained in 2% giemsa (Gurr, BDH Chemicals Ltd., Poole, UK). Karyotypes were determined by the analysis of 20 metaphase spreads. Rappaport (1966) (Figure 1 ). Although the biopsy was small it contained intestinal smooth muscle on its outer aspect indicating that the lymphoma arose in the gastrointestinal tract.
Establishment of lymphoma-derived cell line (DH-BL) and of EB virus-transformed lymphoblastoid cell line (DH-LCL)
In the case of the cultured biopsy cells, after a month of remaining apparently dormant on the human fibroblast feeder layer the lymphoma cells then began to proliferate and were subcultured into plastic tissue culture flasks. The appearance of the line was that of small cells with a slightly irregular outline, growing mainly as a single cell suspension but with some small loose clumps apparent even in the first few passages; clumping became slightly more pronounced after 6 months of continuous culture (Figure 2a) .
EB virus-infected cultures of peripheral blood mononuclear cells gave rise to tight clumps of larger lymphoblastoid cells which could be subcultured within two weeks of infection to establish the LCL (Figure 2b ).
Characterisation of DH biopsy cells, DH-BL and DH-LCL
As shown in Table II and the tumour derived cell line, DH-BL, were EBNA negative and displayed the same monotypic cxA pattern of surface immunoglobulin expression. The tumour cell line also displayed the t(8: 14) (q24q32) translocation (Figure 3 ) which is characteristic of BL (Zech et al., 1976) . In contrast DH-LCL was EBNA positive, polyclonal for both surface and cytoplasmic immunoglobulin and displayed a normal diploid karyotype. These same cell populations were also examined for expression of B cell-associated markers as defined by the monoclonal antibodies listed in Table I . The results of repeated tests are summarised in Table III . The biopsy cell population was found to consist of 20% infiltrating T cells as identified with binding to the antibody OKTII which recognises a pan T cell antigen. The percentages of fluorescent positive biopsy cells in Table III were therefore corrected to account only for the B cell fraction identified by binding to thc pan B cell antigen (recognised by the antibody BI). As expected, the cell populations from both DH-BL and DH-LCL were exclusively B cells as they gave 100% binding with the antibody Bk. Both the tumour biopsy and the derived DH-BL cell line expressed two markers -the common acute lymphoblastic leukaemia antigen cALLA, defined by J5 staining, and the BL-associated antigen BLA, defined by 38.13 staining. These two markers have also been consistently found on all EB viruspositive BL cell lines studied in early passage (Rowe et al., 1985) . In addition the DH-BL cell line even when tested in early passage expressed the Ki-24 antigen on a minority of the cells but did not stain for any of the other 'Iymphoblastoid' antigens defined by the antibodies MHM6, AC2 and Ki-I (see below). DH-BL proved to be essentially stable on continued passaged (from observations over a period of six months) and was clearly distinguishable from that of DH-LCL. The latter cell line selectively bound Ki-24, MHM6, AC2 and Ki-I antibodies exactly as described for all other LCLs thus analysed (Rowe et al., 1985) .
Discussion
The present case report concerns an abdominal lymphoma in an English child which on clinical, histopathological and cytogenetic grounds clearly satisfies the criteria for 'sporadic BL' as employed by other groups (Levine et al., 1982; Philip et al., 1982) . In particular, many features of the histopathology resembled those seen with the endemic disease and the tumour showed a t(8:14) chromosomal translocation, the commonest of three specific translocations consistently observed in association with BL (Berger & Bernheim, 1985) . Like most sporadic BLs in Western Europe (Philip, (Rowe et al., 1985) . These antibodies have recently been used to characterise endemic BL biopsy cells and their derived cell lines ) and the present report represents the first extension of this approach to a case of sporadic BL. The results are interesting in that the cell surface phenotype of the DH-BL biopsy (Table III) was indistinguishable from that shown by all biopsies of EB viruspositive endemic BLs so far examined .
Related work with EB virus-positive BL has revealed a tendency for many of the derived cell lines to progress towards a more 'Iymphoblastoid' phenotype with continued passage in vitro, without loss of the cytogenetic markers indicative of malignant origin (Rowe et al., 1985; Rooney et al., 1986) .
The present results with an EB virus-negative BL cell line are contrary to this general pattern, since continual culture of the DH-BL line was only associated with acquisition of a weak reactivity with the antibody but no further progression towards the 'lymphoblastoid' phenotype. One possibility is that the more dramatic examples of phenotypic progression in vitro represent the influence of a resident EB virus genome upon an otherwise stable BL cell phenotype. This view is indeed supported by the recent observation that several other established EB virus-negative BL cell lines show the same phenotype as described here for DH-BL cells .
The overall inference from these studies is that, despite minor differences in histopathological appearance between the DH tumour and a typical case of endemic BL, the tumour cell surface phenotypes in vivo were indistinguishable (at least by the panel of markers employed). Although much more work will be required, this certainly raises the possibility that both the endemic and sporadic forms of BL are derived from a cALLA-positive BLA-positive subset of progenitor cells. Such a normal subset has not yet been unequivocally defined but it certainly becomes important to search for such normal cells in lymphoid tissue, particularly in mucosa-associated lymphoid tissue where BL is considered to originate (Wright, 1985) . Furthermore it is important to examine the precise position of such cells within the B cell lineage.
